/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

N

Niladri Chattopadhyay

Bayer (Germany)(DE)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

24

Papers

2.0K

Citations

13

h-index

13

i10-index

Niladri Chattopadhyay is an academic researcher from Bayer (Germany). The author has contributed to research in topics: Nanoplatforms for cancer theranostics & Nanoparticle-Based Drug Delivery & Radiation Therapy and Dosimetry. The author has an h-index of 13, co-authored 21 publications.

Research Topics

Nanoplatforms for cancer theranostics Nanoparticle-Based Drug Delivery Radiation Therapy and Dosimetry Advanced Radiotherapy Techniques RNA Interference and Gene Delivery

Papers by this author

works

Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation

2012 · Breast Cancer Research and Treatment · 152 citations

https://doi.org/10.1007/s10549-012-2338-4

Niladri Chattopadhyay Zhongli Cai Yongkyu Luke Kwon Eli Lechtman

Design and Characterization of HER-2-Targeted Gold Nanoparticles for Enhanced X-radiation Treatment of Locally Advanced Breast Cancer

2010 · Molecular Pharmaceutics · 130 citations

https://doi.org/10.1021/mp100207t

Niladri Chattopadhyay Zhongli Cai Jean‐Philippe Pignol Brian Keller

Research topics

topics

Nanoplatforms for cancer theranostics

Nanoparticle-Based Drug Delivery

Radiation Therapy and Dosimetry

Advanced Radiotherapy Techniques

RNA Interference and Gene Delivery

Chat about Author

Papers

Chat

Click to start Chat